Vivoryon Therapeutics N.V. (AMS: VVY)
Netherlands
· Delayed Price · Currency is EUR 2.185
+0.010 (0.46%)
Jan 6, 2025, 9:13 AM CET
Vivoryon Therapeutics Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -31.19 | -28.34 | -28.16 | -12.66 | -16.51 | -7.82 | Upgrade
|
| Depreciation & Amortization | 0.16 | 0.17 | 0.16 | 0.17 | 0.15 | 0.09 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 0.01 | 0.08 | - | - | Upgrade
|
| Stock-Based Compensation | 2.86 | 3.94 | 3.49 | 1.76 | 0.16 | 0.01 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.04 | -0.04 | -0.05 | 0.1 | - | - | Upgrade
|
| Other Operating Activities | 3.08 | 2.97 | 1.73 | -0.13 | 0.51 | -0.02 | Upgrade
|
| Change in Accounts Payable | 0.36 | 0.54 | -1.72 | 3.45 | 0.37 | -0.23 | Upgrade
|
| Change in Other Net Operating Assets | 10.21 | -0.77 | 2.76 | -4.03 | 1.31 | -3.63 | Upgrade
|
| Operating Cash Flow | -14.56 | -21.54 | -21.79 | -11.26 | -14.01 | -11.61 | Upgrade
|
| Capital Expenditures | -0.01 | -0.01 | -0.01 | -0.02 | -0.06 | -0.05 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.5 | -0.5 | -0 | -0.01 | -0.58 | - | Upgrade
|
| Investment in Securities | - | -10 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -0.51 | -10.51 | -0.01 | -0.03 | -0.64 | -0.05 | Upgrade
|
| Long-Term Debt Repaid | - | -0.09 | -0.09 | -0.09 | -0.09 | -0.06 | Upgrade
|
| Net Debt Issued (Repaid) | -0.08 | -0.09 | -0.09 | -0.09 | -0.09 | -0.06 | Upgrade
|
| Issuance of Common Stock | 0.8 | 26.35 | 36 | 1.14 | - | 51.24 | Upgrade
|
| Other Financing Activities | - | -2.1 | -2.53 | -1.88 | - | -1.83 | Upgrade
|
| Financing Cash Flow | 0.73 | 24.16 | 33.38 | -0.83 | -0.09 | 49.35 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | -0.1 | 0.32 | 0.47 | -0.48 | 0.04 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | 0 | Upgrade
|
| Net Cash Flow | -14.31 | -7.99 | 11.89 | -11.65 | -15.22 | 37.74 | Upgrade
|
| Free Cash Flow | -14.56 | -21.56 | -21.81 | -11.28 | -14.08 | -11.66 | Upgrade
|
| Free Cash Flow Margin | - | - | - | -104.77% | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.58 | -0.85 | -0.99 | -0.56 | -0.70 | -0.93 | Upgrade
|
| Cash Interest Paid | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -12.25 | -11.21 | -14.93 | -5.47 | -8.58 | -8.62 | Upgrade
|
| Unlevered Free Cash Flow | -12.22 | -11.18 | -14.91 | -5.46 | -8.58 | -8.6 | Upgrade
|
| Change in Net Working Capital | -4.86 | -2.88 | 0.35 | -0.64 | -1.76 | 3.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.